The Anti-α4β7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation-Reference-Cited by-同舟云学术

The Anti-α4β7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation

Published:2018-08 Issue:8 Volume:113 Page:1261-1263
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Nhu Quan M.,Chiao Hellen,Moawad Fouad J.,Bao Fei,Konijeti Gauree G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/s41395-018-0145-1.pdf

Reference5 articles.

1. Tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives.;Nhu;Front Med (Lausanne),2017

2. The binding specificity and selective antagonism of vedolizumab, an anti-47 integrin therapeutic antibody in development for inflammatory bowel diseases.;Soler;J Pharmacol Exp Ther,2009

3. Integrin 47 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin.;Walsh;Immunology,1996

4. Engagement of 47 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro.;Meerschaert;J Immunol,1999

5. The 47-integrin is dynamically expressed on murine eosinophils and involved in eosinophil trafficking to the intestine.;Brandt;Clin Exp Allergy,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report;Intestinal Research;2024-08-29

2. Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN);Journal of Pediatric Gastroenterology and Nutrition;2024-06-24

3. Eosinophilic esophagitis: Current concepts in diagnosis and management;Saudi Journal of Gastroenterology;2024-05-16

4. Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags;European Journal of Hospital Pharmacy;2024-01-11

5. Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms;Cells;2023-10-18